It’s estimated about one in nine men will be diagnosed with prostate cancer during their lifetime.
“This is our target, this is our bullseye,” pointed Dr. Michael Leapman,
Thanks to this advanced technology, Artemis, the uncertainty of the presence of cancer is more certain.
Dr. Leapman explained, “As the patient’s orientation changes, we don’t want to lose track of where the spot may be, so it moves with us.”
“Essentially, it stimulates kind of what GPS does in your car. It tells us exactly where to put that biopsy needle,” he said.
This allows Dr. Leapman to have a clearer picture of a suspicious area.
“We can confidently tell a patient they do have prostate cancer or do not have prostate cancer and tailor their treatment and their management, which is very often not treatment to their disease,” he said.
Prior to this sophisticated diagnostic tool — Dr. Leapman explained that doctors relied on less accurate information.
“Frequently, about 30 percent of the time, we would miss or undercharacterize cancer that could be prostate, leading to missed, late diagnosis.”
Related Content: Two-time prostate cancer survivor tells his story
The ideal candidates are men with an abnormal PSA level.
The blood screening is controversial after the U.S. Preventive Services Task Force recommended against it in 2012.
Dr. Leapman says, “In May of this year, they reversed their direction and said that screening could be considered in men age 55 – 69, but that decision should occur in the context of a careful conversation with their doctor.”
He said Yale Urology believes that healthy, well-informed men benefit from PSA testing – but that it needs to be a shared decision with their doctor.
A men’s health fair hosted by Smilow Cancer Hospital at Yale New Haven is happening Thursday, Nov. 1st from 5:00 p.m. to 7:00 p.m.
It will offer free prostate cancer screening — along with information on sexual dysfunction, blood pressure and smoking cessation.
You can register online or by calling 888-700-6543.
For more information, contact: firstname.lastname@example.org